Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study : Official journal of the American College of Gastroenterology | ACG

Secondary Logo

Journal Logo

ARTICLE: INFLAMMATORY BOWEL DISEASE

Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study

Narula, Neeraj MD, MPH, FRCPC1; Wong, Emily C.L. BHSc1; Marshall, John K. MD, MSc, FRCPC1; Jairath, Vipul MD, PhD2; Dulai, Parambir S. MD3,*; Reinisch, Walter MD, PhD4,*

Author Information
The American Journal of Gastroenterology 118(1):p 121-128, January 2023. | DOI: 10.14309/ajg.0000000000001987

Abstract

© 2022 by The American College of Gastroenterology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid